article thumbnail

Bodyport Presents Preliminary Analysis of SCALE-HF 1 Study on Remote Heart Failure Monitoring at Technology and Heart Failure Therapeutics (THT) Conference

DAIC

a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.

article thumbnail

Researchers developed new method for detecting heart failure with a smartphone

Science Daily - Heart Disease

New technology uses a smartphone to analyze heart movement and detect heart failure.

article thumbnail

FDA Approves Digital Health Solution for Heart Failure Management

DAIC

recently announced that Digitiva, a non-invasive digital health solution for heart failure management, has been listed with the U.S. a smartphone app designed for heart failure patients and built on the Welldoc, Inc. a smartphone app designed for heart failure patients and built on the Welldoc, Inc.

article thumbnail

A discourse on primary prevention implantable cardioverter-defibrillators for heart failure is understandable, but answers must be sought appropriately

HeartRhythm

Data supporting the role of primary prevention ICDs in patients with heart failure were generated by rigorous randomized controlled trials (RCTs).1 1 During this time period, numerous advances in ICD technology, care, and follow-up have resulted in unequivocal improvement in the outcomes of patients with an ICD.

article thumbnail

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

DAIC

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111
article thumbnail

Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology

DAIC

The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heart failure (ADHF) who are unresponsive to standard medical therapy. I am excited to be able to include the advanced heart failure patients in the trial," commented Dr. Grafton.

article thumbnail

Remote patient monitoring in heart failure: A comprehensive meta‐analysis of effective programme components for hospitalization and mortality reduction

European Journal of Heart Failure

Remote patient monitoring in heart failure (HF). Abstract Aims Methods of non-invasive remote patient monitoring (RPM) for heart failure (HF) remain diverse. Modernizing RPM with advanced technologies like non-invasive sensors, artificial intelligence, and cardiac telerehabilitation could enhance its potential.